Clinical Trial Results:
A phase-III study on the value of allogeneic stem cell transplantation in poor-risk chronic lymphocytic leukemia by the German CLL Study Group (GCLLSG) and the German Cooperative Transplant Study Group (GCTSG) (GCLLSG/GCTSG CLL-X2 protocol)
Summary
|
|
EudraCT number |
2008-001669-27 |
Trial protocol |
DE |
Global completion date |
20 Jul 2011
|
Paediatric regulatory details
|
|
Is the trial part of an agreed EMA paediatric investigation plan? |
No
|
Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? |
No
|
Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? |
No
|
Results information
|
|
Results version number |
v1(current) |
This version publication date |
08 Apr 2020
|
First version publication date |
08 Apr 2020
|
Other versions |
|
Summary report(s) |
2008-001669-27 Statement |
Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to Commission Guideline 2012/C 302/03
for further information.